hives - Nursing Case Study

Pathophysiology

• Primary mechanism: Mast cell degranulation releases histamine and other inflammatory mediators, increasing vascular permeability and leading to the characteristic wheals of urticaria.

• Secondary mechanism: Activation of the complement pathway, often triggered by allergens, infections, or stress, further amplifies the inflammatory response by attracting additional immune cells to the site.

• Key complication: Severe cases may progress to angioedema, where deeper dermal and subcutaneous tissues swell, posing risks of airway obstruction and requiring immediate medical intervention.

Patient Profile

Demographics:

53-year-old female, laboratory technician

History:

• Key past medical history: Chronic idiopathic urticaria, asthma, hypothyroidism

• Current medications: Levothyroxine, montelukast, cetirizine, albuterol inhaler as needed

• Allergies: Penicillin, shellfish

Current Presentation:

• Chief complaint: Severe, persistent hives and difficulty breathing

• Key symptoms: Extensive skin rash with intense itching, angioedema of the lips and tongue, wheezing, shortness of breath

• Vital signs: Blood pressure 90/60 mmHg, heart rate 130 bpm, respiratory rate 28 breaths per minute, temperature 101.3°F, oxygen saturation 88% on room air

Section 1

As the medical team initiates emergency interventions, the patient's condition deteriorates rapidly. Despite administration of high-flow oxygen, her oxygen saturation continues to drop, reaching a critical level of 82%. Her respiratory distress intensifies, indicated by increased use of accessory muscles and intercostal retractions. The wheezing becomes more pronounced with each labored breath, and her heart rate spikes to 140 bpm. The patient displays signs of cyanosis around the lips and fingertips, suggesting severe hypoxia. Her blood pressure further declines to 85/55 mmHg, prompting concerns about impending anaphylactic shock.

Immediate laboratory results reveal a markedly elevated tryptase level, confirming substantial mast cell activation. A complete blood count shows leukocytosis with a differential indicating eosinophilia, suggestive of an allergic or hypersensitivity reaction. Arterial blood gases demonstrate a concerning picture: pH 7.28, PaCO2 50 mmHg, and PaO2 55 mmHg, indicating acute respiratory acidosis and hypoxemia. The team considers intubation to secure the airway, given the potential for rapid progression to complete airway obstruction due to worsening angioedema.

In response to these critical findings, the medical team administers intravenous epinephrine, corticosteroids, and antihistamines, aiming to counteract the severe allergic reaction. A second-line treatment with an intravenous beta-agonist is considered to address the bronchospasm and enhance bronchodilation. The patient's responsiveness to these interventions will be closely monitored, determining the need for further escalation of care, including potential ICU admission for advanced respiratory support and continuous hemodynamic monitoring.

Section 2

As the medical team continues to administer emergency interventions, they observe a gradual but not entirely reassuring change in the patient’s status. Following the administration of intravenous epinephrine and corticosteroids, there is a slight improvement in her oxygen saturation, which rises to 85%, though it remains critically low. The cyanosis around her lips and fingertips persists, indicating ongoing severe hypoxia. Her heart rate decreases slightly to 130 bpm, but her blood pressure remains dangerously low at 88/56 mmHg, suggesting that while the vasopressor effects of epinephrine are beginning to take hold, they are not yet sufficient to stabilize her hemodynamics fully. The patient's respiratory distress is still significant, with continued use of accessory muscles and pronounced wheezing, though her intercostal retractions show minimal improvement.

New diagnostic results provide additional insights into the complexity of her condition. A chest X-ray reveals pulmonary edema, raising concerns about possible fluid overload or worsening capillary leak syndrome secondary to severe anaphylaxis. The echocardiogram, performed to assess cardiac function, shows reduced ejection fraction at 45%, which is an unexpected finding given the acute nature of the event and suggests potential myocardial involvement, possibly related to stress-induced cardiomyopathy or direct effects of the systemic allergic response. The combination of these findings necessitates a reevaluation of the patient's treatment plan, with considerations for diuretic therapy to manage pulmonary congestion and inotropic support to enhance cardiac output.

Despite initial therapeutic efforts, a new complication emerges as the patient begins to exhibit signs of altered mental status, becoming increasingly lethargic and disoriented. This change prompts immediate re-evaluation of her neurological status and calls for urgent neuroimaging to rule out hypoxic brain injury or other central nervous system involvement. The medical team faces the challenge of balancing aggressive management of her respiratory and hemodynamic instability while addressing this new neurological concern, underscoring the need for advanced critical thinking and continuous reassessment as they prepare for a potential transfer to the intensive care unit for comprehensive monitoring and support.

Section 3

As the medical team intensifies their efforts to stabilize the patient, her altered mental status becomes a focal point of concern. A stat CT scan of the brain is performed, revealing no acute intracranial hemorrhage or ischemic stroke but does show cerebral edema, likely secondary to prolonged hypoxia. This finding necessitates immediate intervention to prevent further neurological compromise. The team initiates measures to manage intracranial pressure, including the administration of hypertonic saline and elevation of the head of the bed, while maintaining close monitoring of her neurological status.

Concurrent with these developments, laboratory results return with alarming findings. Her arterial blood gas analysis shows a pH of 7.25, indicating severe acidosis, alongside elevated lactate levels of 6 mmol/L. These results suggest a combination of respiratory and metabolic acidosis, likely exacerbated by ongoing tissue hypoxia and impaired perfusion. The team considers the initiation of bicarbonate therapy to buffer the acidosis while optimizing ventilation strategies to improve oxygenation and carbon dioxide clearance. Her complete blood count reveals leukocytosis with a neutrophilic predominance, raising the possibility of an infectious process complicating her already critical state.

Despite these interventions, the patient's condition remains precarious. Her oxygen saturation fluctuates between 80-85%, and her blood pressure continues to require support with escalating doses of vasopressors. The team deliberates the need for advanced airway management, including potential intubation and mechanical ventilation, to secure her airway and improve oxygenation. This decision is weighed against the risks of further hemodynamic instability and the challenge of managing pulmonary edema in a mechanically ventilated patient. The possibility of extracorporeal membrane oxygenation (ECMO) is also considered as a bridge to stabilize her respiratory and cardiac function. The complexity of her condition demands ongoing reassessment and multidisciplinary collaboration as the team navigates the next critical steps in her care.

Section 4

The medical team decides to proceed with intubation and mechanical ventilation to secure the patient's airway and attempt to stabilize her oxygenation status. As the team prepares for the procedure, they carefully review her current hemodynamic parameters and discuss strategies to mitigate the risk of further destabilization. Her blood pressure is critically low, at 78/45 mmHg, despite maximal vasopressor support, and her heart rate remains elevated at 130 beats per minute. The team prepares for a rapid-sequence intubation with meticulous attention to pre-oxygenation and plans to use a low-dose induction agent to minimize cardiovascular depression.

Once intubated, the patient is placed on a mechanical ventilator with settings optimized to address her severe respiratory acidosis and hypoxia. An arterial blood gas drawn post-intubation reveals slight improvement in oxygenation, with a PaO2 of 60 mmHg, but her pH remains critically low at 7.28, and PaCO2 elevated at 65 mmHg, indicating persistent hypercapnia. This necessitates adjustments in ventilator settings to improve alveolar ventilation and CO2 clearance. Despite the adjustments, her oxygen saturation remains tenuous, hovering around 85-88%.

Simultaneously, new diagnostic results from her blood cultures return, confirming a bloodstream infection with a multi-drug resistant organism. This finding introduces a significant complication in her management, requiring the initiation of targeted antibiotic therapy with a combination of high-dose vancomycin and meropenem. The team is aware of the potential nephrotoxic effects of this regimen, especially given her current state of shock and renal hypoperfusion. It is imperative to closely monitor her renal function, electrolyte balance, and overall response to therapy. The unfolding scenario demands an integrative approach, balancing aggressive infection control with the delicate management of her critical respiratory and hemodynamic status. As the team navigates these complexities, they continue to reassess her condition, ready to adapt their strategy in response to her evolving clinical picture.

Section 5

As the team continues to navigate the intricate balance of managing the patient's critical condition, they note a sudden change in her status. Approximately six hours post-intubation, the patient's urine output decreases precipitously to less than 10 mL/hour, raising concerns about impending acute kidney injury. A repeat set of arterial blood gases indicates a further decline in her metabolic status, with a pH now at 7.25 and a bicarbonate level of 18 mmol/L, suggesting a worsening metabolic acidosis on top of her respiratory acidosis. Her potassium level is also noted to be climbing, now at 5.8 mmol/L, indicating potential hyperkalemia, which poses additional risks for cardiac complications given her already strained hemodynamic state.

In response to these developments, the medical team deliberates on the need for renal replacement therapy, such as continuous venovenous hemofiltration (CVVH), to manage her fluid balance and electrolyte disturbances while minimizing additional cardiovascular strain. They are acutely aware of the delicate interplay between her respiratory, renal, and cardiovascular systems and the necessity of a coordinated, multidisciplinary approach to address these challenges. The decision to initiate CVVH is made with caution, considering the patient's ongoing hemodynamic instability and the potential for further complications.

While commencing renal support, the team simultaneously reassesses her antibiotic regimen, given the confirmed multi-drug resistant organism and her deteriorating renal function. They maintain vigilant monitoring of her renal and hepatic function, adjusting doses as necessary to optimize therapeutic efficacy while minimizing toxicity. As the patient's clinical picture evolves, the team remains poised to adjust their management strategy, continuously integrating new data and clinical insights to guide their interventions. This intricate dance of medical management underscores the critical need for advanced clinical reasoning and adaptive decision-making in the face of complex, multi-system challenges.